Variagenics: Zooming in on variety

Emerging Company Profile

Genetic variance in the population is a given. The question is how to apply that variance to drug development. Variagenics Inc.'s answer is to focus both on genetic variance in populations and on genetic differences between diseased and healthy tissue.

The company has developed a process that rapidly identifies genetic variants in a population and has applied the technology to narrowly defined drug discovery programs that exemplify the kinds of niche therapies that variance-based discovery - or pharmacogenomics - can

Read the full 831 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE